Others

Bafna Pharmaceuticals Ltd. - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

| Updated on February 14, 2019

Sub: Implementation of the Resolution Plan / Capital Reduction

This is in continuation of our earlier intimation dated 05th February 2019 regarding resolution plan which was approved by NCLT, Chennai vide its order dated 01st February 2019 under the Provisions of IBC, 2016.

Pursuant to the Resolution Plan a capital reduction is proposed and the capital of the fully paid up equity shareholders shall be reduced to 10% and consequently the existing 2.36 Crores number of shares shall be reduced to 0.236 Crores.

The Stock exchanges will be intimated in due course for effecting capital reduction.

This is for your information and record.

Pdf Link: Bafna Pharmaceuticals Ltd. - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

Source : BSE - www.bseindia.com

Published on February 14, 2019

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor